Literature DB >> 27393859

Serum neprilysin and recurrent hospitalizations after acute heart failure.

Julio Núñez1, Eduardo Núñez2, Gema Miñana2, Arturo Carratalá3, Juan Sanchis2, Josep Lupón4, Jaume Barallat5, Maria Cruz Pastor5, Domingo Pascual-Figal6, Antoni Bayés-Genís4.   

Abstract

Entities:  

Keywords:  Acute heart failure; Neprilysin; Rehospitalizations

Mesh：

Substances：

Year:  2016        PMID： 27393859     DOI： 10.1016/j.ijcard.2016.06.271

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  8 in total

1.  Soluble Neprilysin in the General Population: Clinical Determinants and Its Relationship to Cardiovascular Disease.

Authors:  Yogesh N V Reddy; Seethalakshmi R Iyer; Christopher G Scott; Richard J Rodeheffer; Kent Bailey; Gregory Jenkins; Anthony Batzler; Margaret M Redfield; John C Burnett; Naveen L Pereira
Journal:  J Am Heart Assoc       Date:  2019-07-26       Impact factor: 5.501

Review 2.  Soluble neprilysin: A versatile biomarker for heart failure, cardiovascular diseases and diabetic complications-A systematic review.

Authors:  Kumaresan Ramanathan; Giri Padmanabhan
Journal:  Indian Heart J       Date:  2020-02-04

3.  Effects of Angiotensin II Type 1A Receptor on ACE2, Neprilysin and KIM-1 in Two Kidney One Clip (2K1C) Model of Renovascular Hypertension.

Authors:  Laale F Alawi; Sanjeev Dhakal; Sana E Emberesh; Harshal Sawant; Anhar Hosawi; Unmesha Thanekar; Nadja Grobe; Khalid M Elased
Journal:  Front Pharmacol       Date:  2021-01-29       Impact factor: 5.810

Review 4.  Biomarkers in Heart Failure with Preserved Ejection Fraction.

Authors:  Antoni Bayes-Genis; Germán Cediel; Mar Domingo; Pau Codina; Evelyn Santiago; Josep Lupón
Journal:  Card Fail Rev       Date:  2022-06-23

5.  Serum Neprilysin and Recurrent Admissions in Patients With Heart Failure.

Authors:  Julio Núñez; Eduardo Núñez; Jaume Barallat; Vicent Bodí; Gema Miñana; M Cruz Pastor; Juan Sanchis; Josep Lupón; Antoni Bayes-Genis
Journal:  J Am Heart Assoc       Date:  2017-08-18       Impact factor: 5.501

6.  Soluble neprilysin does not correlate with prognosis in pulmonary hypertension.

Authors:  Akiomi Yoshihisa; Tetsuro Yokokawa; Tomofumi Misaka; Masayoshi Oikawa; Atsushi Kobayashi; Takayoshi Yamaki; Koichi Sugimoto; Hiroyuki Kunii; Kazuhiko Nakazato; Yasuchika Takeishi
Journal:  ESC Heart Fail       Date:  2019-01-25

7.  Soluble neprilysin and long-term clinical outcomes in patients with coronary artery disease undergoing percutaneous coronary intervention: a retrospective cohort study.

Authors:  Ik Jun Choi; Sungmin Lim; Youngdeok Hwang; Dongjae Lee; Won Jik Lee; Kwan Yong Lee; Mi-Jeong Kim; Doo Soo Jeon
Journal:  BMC Cardiovasc Disord       Date:  2020-08-06       Impact factor: 2.298

8.  The influence of sex and body mass index on the association between soluble neprilysin and risk of heart failure hospitalizations.

Authors:  Julio Núñez; Eduardo Núñez; Elena Revuelta-López; Gema Miñana; Jaume Barallat; Vicent Bodi; Juan Sanchis; Alberto Aimo; Michele Emdin; Josep Lupón; Oliver Husser; Antoni Bayes-Genis
Journal:  Sci Rep       Date:  2021-03-15       Impact factor: 4.379
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.